In our study, PIK3CA appeared to be a frequently altered gene in cervical adenocarcinoma, with missense mutations in 4 of 20 (20%) tumors, consistent with previous reports (8–37.5%) [45, 47]. This evidence concerns the gene PIK3CA and cervical adenocarcinoma.